Savaria Corp
TSX:SIS

Watchlist Manager
Savaria Corp Logo
Savaria Corp
TSX:SIS
Watchlist
Price: 25.15 CAD 1.78% Market Closed
Market Cap: CA$1.8B

Savaria Corp
Investor Relations

Savaria Corp. engages in the provision of accessibility solutions for the physically challenged individuals. The company is headquartered in Laval, Quebec and currently employs 1,605 full-time employees. The company went IPO on 2001-04-20. Its segments include Accessibility, Patient Handling and Adapted Vehicles. The Accessibility segment includes designing, manufacturing, distributing and installing a wide portfolio of products, including stairlifts for both straight and curved stairs, vertical and inclined wheelchair platform lifts for both commercial and residential applications, commercial accessibility elevators and home elevators. The Patient Handling segment includes the manufacturing and distributing of a comprehensive line of therapeutic support surfaces and other pressure management products for the medical market, medical beds for the long-term care market. The Adapted Vehicles segment consists of converting, adapting and distributing vehicles for people with mobility challenges, for personal or commercial use.

Show more
Loading
SIS
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 6, 2025
AI Summary
Q3 2025

Strong Margins: Savaria achieved record EBITDA margin of 21.2% in Q3, exceeding its 20% target for the second consecutive quarter, driven by operational improvements and pricing initiatives.

Gross Margin Peaks: Gross margin reached 39.2%, up 220 basis points year-over-year, marking the highest in company history.

Revenue Growth: Q3 revenue grew to $224.8 million, an increase of 5.2% from last year, with organic growth of 1.8% and positive currency and acquisition impacts.

Guidance Maintained: Annual revenue guidance remains unchanged at about $925 million, while EBITDA margin guidance was updated to slightly above 20%.

Solid Cash Flow & Deleveraging: Free cash flow improved significantly to $20.6 million, and the net debt-to-EBITDA ratio dropped to 1.19, providing flexibility for future acquisitions.

Outlook Focused on Growth: Management emphasized a shift from margin improvement to driving organic and acquisitive growth, with a new five-year plan being unveiled in April 2026.

Key Financials
Revenue
$224.8 million
Gross Margin
39.2%
EBITDA Margin
21.2%
Adjusted EBITDA
$47.6 million
Net Earnings
$19.5 million
EPS
$0.27 per share
Operating Cash Flow
$41.5 million
CapEx
$5.7 million (2.5% of sales)
Free Cash Flow
$20.6 million
Leverage Ratio (Net Debt/EBITDA)
1.19
Accessibility Segment EBITDA Margin
23.5%
Patient Care Segment EBITDA Margin
18.3%
Accessibility Segment Revenue Growth
6.1%
North America Accessibility Revenue Growth
7.7%
Europe Accessibility Revenue Growth
3.6%
Patient Care Revenue Growth
1.9%
Earnings Call Recording
Other Earnings Calls

Management

Mr. Marcel Bourassa BAA
Executive Chairman
No Bio Available
Mr. Sebastien Bourassa
President, CEO & Director
No Bio Available
Mr. Stephen Reitknecht C.A., CPA
Chief Financial Officer
No Bio Available
Ms. Clare Brophy
President of EUROW Accessibility
No Bio Available
Mr. Les Teague
Group President of Patient Care
No Bio Available
Mr. Sylvain Aubry
Chief Legal Officer & Corporate Secretary
No Bio Available
Mr. Charles Nicolas Rimbert
Vice President of Corporate Development
No Bio Available
Ms. Laureen Cushing
Global Vice President of Human Resources
No Bio Available
Mr. Alexandre Bourassa
President of North America Accessibility
No Bio Available
Mr. Jean-Philippe De Montigny
Chief Transformation Officer
No Bio Available

Contacts

Address
QUEBEC
Laval
4350 Chomedey (A-13) W
Contacts
+14504379414.0
www.savaria.com